pentobarbital will lower the level or effect of isavuconazonium sulfate by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Contraindicated.pentobarbital will decrease the extent or outcome of montelukast by influencing hepatic/intestinal enzyme CYP3A4 metabolism. Minimal/Importance Unidentified.These research have substantial constraints,